Last reviewed · How we verify

Perazyl (CHLORCYCLIZINE)

FDA-approved active Small molecule ✓ Verified May 2026 Quality 23/100

Perazyl (generic name: CHLORCYCLIZINE) is a chlorcyclizine drug. It is currently FDA-approved for Allergic conjunctivitis, Allergic rhinitis, Common cold.

Perazyl is a small molecule with the synonyms ALERGICIDE, CHLORCYCLIZINE, and others.

At a glance

Generic nameCHLORCYCLIZINE
Drug classchlorcyclizine
TargetApoptosis regulator Bcl-2
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Perazyl

What is Perazyl?

Perazyl (CHLORCYCLIZINE) is a chlorcyclizine drug, indicated for Allergic conjunctivitis, Allergic rhinitis, Common cold.

What is Perazyl used for?

Perazyl is indicated for Allergic conjunctivitis, Allergic rhinitis, Common cold, Cough, Nasal congestion.

What is the generic name of Perazyl?

CHLORCYCLIZINE is the generic (nonproprietary) name of Perazyl.

What drug class is Perazyl in?

Perazyl belongs to the chlorcyclizine class. See all chlorcyclizine drugs at /class/chlorcyclizine.

What development phase is Perazyl in?

Perazyl is FDA-approved (marketed).

What does Perazyl target?

Perazyl targets Apoptosis regulator Bcl-2 and is a chlorcyclizine.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing